Topic One: Lectures of the third day
The 3rd PMDA Training Seminar has been reached the middle of the course.
The more specialized topics were lectured based on the three themes of Risk Management Plan, Information Services and Medical Information for Risk Assessment Initiative (*MIHARI) on the third day. The discussions were earnestly exchanged between lecturers and participants again today.
Topic Two: *MIHARI Project
This project is the "MIHARI project"/Medical Information for Risk Assessment Initiative. "MIHARI" means "monitoring" in Japanese.
The project on the use of electronic medical records, etc. for safety measures was launched in 2009, as one of the activities for reinforcement and enhancement of the system for safety information collection and evaluation of medical products.
Please refer to the following URL for the details of MIHARI Project.
/english/safety/surveillance-analysis/0001.html
Topic Three: Presentation by the participant from Health Sciences Authority (HSA)
After the program DAY3, the participants from Health Sciences Authority (HSA), Singapore made a presentation on the outline of HAS and its regulatory system of pharmaceutical affairs.
Many questions from other participants of the seminar and PMDA attendees were asked about their wide-ranging presentation on the regulatory system of pharmaceutical affairs.
Comments from participants
 It's our pleasure to be able to participate in the 3rd PMDA Training Seminar, 2013 and thank you again for inviting us. It's a wonderful experience and opportunity to learn more about the post-marketing safety issues in Japan.
Ms. Lan-Hui Chih and Ms. Hui-Yi Wu, Taiwan Drug Relief Foundation (TDRF), Taiwan |
 MIYAKOJIMA, Okinawa |
